Next Article in Journal
Decision Support Model for Integrating the New Cross-Compliance Rules and Rational Water Management
Previous Article in Journal
The Association of Oral Processing and Salivary Flow Rate on Food Intake and Appetite in Older Adults (Aged ≥ 65 Years)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

The Effect of Higenamine Supplementation on the Fatty Acid Profiles of Serum Phospholipids †

by
Jelena Rasic Ozegovic
1,2,*,
Marija Takic
3,
Nevena Ivanovic
2,
Danijela Ristic-Medic
3,
Milica Vukasinovic Vesic
1,4 and
Brizita Djordjevic
2
1
Anti-Doping Agency of Serbia, 11000 Belgrade, Serbia
2
Department of Bromatology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia
3
Centre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11221 Belgrade, Serbia
4
Faculty of Sports “Union-Nikola Tesla”, University of Belgrade, 11070 Belgrade, Serbia
*
Author to whom correspondence should be addressed.
Presented at the 14th European Nutrition Conference FENS 2023, Belgrade, Serbia, 14–17 November 2023.
Proceedings 2023, 91(1), 213; https://doi.org/10.3390/proceedings2023091213
Published: 4 February 2024
(This article belongs to the Proceedings of The 14th European Nutrition Conference FENS 2023)

Abstract

:
Background and objectives: Higenamine is an alkaloid found in different plant species like Aconitum japonica, Nandina domestica, Gnetum parvifolium, and Asarum heterotropoides. According to the available data in the literature, its dietary intake leads to an enhancement of lipolysis. The objective of this study was to explore whether the ingestion of a one-component higenamine supplement (75 mg/day) for three weeks would introduce some changes in the fatty acid (FA) profiles of serum phospholipids of female recreational athletes. Methods: A total of 12 female recreational athletes were included in a double-blind study, with six participants in both groups—a higenamine treatment group and placebo group. Serum phospholipids were isolated via one-dimensional thin-layer chromatography. Fatty acid methyl ester samples from the phospholipids were analyzed by a gas–liquid chromatography method. Desaturase and elongase activities were calculated from product/precursor FA ratios. Results: In the group that was undergoing higenamine treatment, a statistically significant increase in the levels of linolenic acid, a total n − 6 polyunsaturated FAs (PUFAs), and an n − 6/n − 3 FA ratio were observed. But saturated palmitic acid and monounsaturated palmitoleic and oleic acid, as well as consequent total saturated FAs and monounsaturated FA acids decreased in serum phospholipids. Also, after 3 weeks of higenamine supplementation, arachidonic n − 6 acid and docosapentaenoic n − 3 acids levels were significantly decreased, and estimated delta-5 desaturase activity (arachidonic/dihomo-gamma-linolenic acid ratio) was decreased too. In the placebo group, a significant change was increased levels of oleic acid compared to baseline levels. Conclusion: According to the results obtained for the FA status of serum phospholipids, treatment with higenamine was followed by a modulation of serum phospholipid FA profiles. Furthermore, this could influence the desaturation/elongation metabolic pathway of endogenous FA metabolisms, leading to a decrease in delta-5 desaturase activity and consequently lower levels of long-chain PUFAs. For further discussion, it is necessary to assess the dietary intake of study participants.

Author Contributions

Conceptualization, J.R.O. and M.T.; methodology, D.R.-M. and M.T.; software, J.R.O.; validation, D.R.-M., N.I. and M.T.; formal analysis, J.R.O.; investigation, J.R.O., N.I., D.R.-M. and B.D.; resources, J.R.O.; data curation, N.I.; writing—original draft preparation, J.R.O.; writing—review and editing, J.R.O., M.T. and D.R.-M.; visualization, M.V.V.; supervision, B.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by Ethics Committee of the Sports Medicine Association of Serbia for studies involving humans.

Informed Consent Statement

Informed consent was obtained from all participants involved in the study. Written informed consent has been obtained from the participant(s) to publish this paper.

Data Availability Statement

The data presented in this study are available on request from the corresponding author (privacy reasons).

Conflicts of Interest

The authors declare no conflicts of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rasic Ozegovic, J.; Takic, M.; Ivanovic, N.; Ristic-Medic, D.; Vukasinovic Vesic, M.; Djordjevic, B. The Effect of Higenamine Supplementation on the Fatty Acid Profiles of Serum Phospholipids. Proceedings 2023, 91, 213. https://doi.org/10.3390/proceedings2023091213

AMA Style

Rasic Ozegovic J, Takic M, Ivanovic N, Ristic-Medic D, Vukasinovic Vesic M, Djordjevic B. The Effect of Higenamine Supplementation on the Fatty Acid Profiles of Serum Phospholipids. Proceedings. 2023; 91(1):213. https://doi.org/10.3390/proceedings2023091213

Chicago/Turabian Style

Rasic Ozegovic, Jelena, Marija Takic, Nevena Ivanovic, Danijela Ristic-Medic, Milica Vukasinovic Vesic, and Brizita Djordjevic. 2023. "The Effect of Higenamine Supplementation on the Fatty Acid Profiles of Serum Phospholipids" Proceedings 91, no. 1: 213. https://doi.org/10.3390/proceedings2023091213

Article Metrics

Back to TopTop